🇫🇷 Lynozyfic in France

Lynozyfic (LINVOSELTAMAB) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Lynozyfic
  • Status: approved

Lynozyfic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in France

Frequently asked questions

Is Lynozyfic approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for Lynozyfic in France?

Rengeneron Pharmaceuticals, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.